RCS - IQ-AI Limited - Imaging Biometrics Installs IB Nimble™ For MCW

IQ-AIAnnouncement

19/07/2023 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230719:nRSS4209Ga&default-theme=true

RNS Number : 4209G  IQ-AI Limited  19 July 2023

19 July 2023

IQ-AI Ltd

("IQ-AI" or the "Company")

 

Imaging Biometrics Installs IB Nimble™ For MCW Bone Mets Treatment

 

Imaging Biometrics, LLC (IB), a wholly-owned subsidiary of IQ-AI Ltd (LSE:
IQAI, OTCQB: IQAIF), today announced that its handheld application, IB Nimble,
has been adopted by Orthopedic Department of the Medical College of Wisconsin
for use in their treatment of bone metastases. The handheld app provides
real-time collaboration
(https://www.imagingbiometrics.com/press_releases/imaging-biometrics-and-the-medical-college-of-wisconsin-awarded-nih-grant/)
amongst multi-disciplinary teams securely and asynchronously.

 

Designed initially by Dr. Joseph Bovi, MD, Professor of Radiation Oncology and
Neurosurgery at MCW, for brain metastases, IB Nimble's base functionality has
been enhanced to accommodate any disease or pathology that requires
multi-disciplinary input. The clinical benefit of providing optimized
treatments faster to patients with brain metastases is now being afforded to
patients with bone mets.

 

"This marks the first installation for use in diseases sites other than brain
metastases and demonstrates that IB Nimble is ready for widespread
deployment," said Josh McComack, IB's Director of Software Engineering.

 

--ENDS-

 

The Directors of the Company accept responsibility for the contents of this
announcement.

 

For further information, please contact:

 

 IQ-AI Ltd

 Trevor Brown/Vinod Kaushal/Brett Skelly/Michael Schmainda

 Tel: 020 7469 0930
 Peterhouse Capital Limited (Financial Adviser and Broker)

 Lucy Williams/Heena Karani

 Tel: 020 7220 9797

 

About Imaging Biometrics® LLC:  IB is a wholly-owned subsidiary of IQ-AI
Limited, (LON: IQAI) (OTCQB: IQAIF), and focuses on delivering quantitative
imaging platforms and therapeutics that transform how clinicians diagnose and
treat patients more efficiently and effectively. For more information about
Imaging Biometrics, visit the company's website at www.imagingbiometrics.com
(http://www.imagingbiometrics.com/) . Follow IB on Twitter, @IQAI_IB.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRARPMATMTABBIJ